nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—forebrain—attention deficit hyperactivity disorder	0.0198	0.0413	CbGeAlD
Arsenic trioxide—CCND1—cardiovascular system—attention deficit hyperactivity disorder	0.0167	0.0349	CbGeAlD
Arsenic trioxide—MAPK1—forebrain—attention deficit hyperactivity disorder	0.0167	0.0348	CbGeAlD
Arsenic trioxide—TXNRD1—forebrain—attention deficit hyperactivity disorder	0.0155	0.0324	CbGeAlD
Arsenic trioxide—MAPK3—forebrain—attention deficit hyperactivity disorder	0.0148	0.0308	CbGeAlD
Arsenic trioxide—MAPK1—cardiovascular system—attention deficit hyperactivity disorder	0.0141	0.0294	CbGeAlD
Arsenic trioxide—AKT1—forebrain—attention deficit hyperactivity disorder	0.0139	0.029	CbGeAlD
Arsenic trioxide—TXNRD1—cardiovascular system—attention deficit hyperactivity disorder	0.0131	0.0274	CbGeAlD
Arsenic trioxide—CCND1—midbrain—attention deficit hyperactivity disorder	0.0131	0.0272	CbGeAlD
Arsenic trioxide—MAPK3—cardiovascular system—attention deficit hyperactivity disorder	0.0125	0.026	CbGeAlD
Arsenic trioxide—JUN—forebrain—attention deficit hyperactivity disorder	0.0121	0.0253	CbGeAlD
Arsenic trioxide—AKT1—cardiovascular system—attention deficit hyperactivity disorder	0.0118	0.0245	CbGeAlD
Arsenic trioxide—CCND1—nervous system—attention deficit hyperactivity disorder	0.0108	0.0224	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—attention deficit hyperactivity disorder	0.0104	0.0216	CbGeAlD
Arsenic trioxide—TXNRD1—midbrain—attention deficit hyperactivity disorder	0.0103	0.0214	CbGeAlD
Arsenic trioxide—JUN—cardiovascular system—attention deficit hyperactivity disorder	0.0103	0.0214	CbGeAlD
Arsenic trioxide—IKBKB—cardiovascular system—attention deficit hyperactivity disorder	0.0102	0.0212	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—attention deficit hyperactivity disorder	0.0101	0.0211	CbGeAlD
Arsenic trioxide—MAPK3—midbrain—attention deficit hyperactivity disorder	0.00975	0.0203	CbGeAlD
Arsenic trioxide—AKT1—midbrain—attention deficit hyperactivity disorder	0.0092	0.0192	CbGeAlD
Arsenic trioxide—MAPK1—nervous system—attention deficit hyperactivity disorder	0.00906	0.0189	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—attention deficit hyperactivity disorder	0.00872	0.0182	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—attention deficit hyperactivity disorder	0.00853	0.0178	CbGeAlD
Arsenic trioxide—TXNRD1—nervous system—attention deficit hyperactivity disorder	0.00843	0.0176	CbGeAlD
Arsenic trioxide—CCND1—brain—attention deficit hyperactivity disorder	0.00822	0.0171	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—attention deficit hyperactivity disorder	0.00812	0.0169	CbGeAlD
Arsenic trioxide—MAPK3—nervous system—attention deficit hyperactivity disorder	0.00802	0.0167	CbGeAlD
Arsenic trioxide—JUN—midbrain—attention deficit hyperactivity disorder	0.00801	0.0167	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—attention deficit hyperactivity disorder	0.00794	0.0165	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—attention deficit hyperactivity disorder	0.00772	0.0161	CbGeAlD
Arsenic trioxide—AKT1—nervous system—attention deficit hyperactivity disorder	0.00756	0.0157	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—attention deficit hyperactivity disorder	0.00755	0.0157	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—attention deficit hyperactivity disorder	0.00728	0.0152	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—attention deficit hyperactivity disorder	0.00712	0.0148	CbGeAlD
Arsenic trioxide—MAPK1—brain—attention deficit hyperactivity disorder	0.00693	0.0144	CbGeAlD
Arsenic trioxide—JUN—nervous system—attention deficit hyperactivity disorder	0.00658	0.0137	CbGeAlD
Arsenic trioxide—IKBKB—nervous system—attention deficit hyperactivity disorder	0.00655	0.0136	CbGeAlD
Arsenic trioxide—TXNRD1—brain—attention deficit hyperactivity disorder	0.00645	0.0134	CbGeAlD
Arsenic trioxide—JUN—central nervous system—attention deficit hyperactivity disorder	0.00634	0.0132	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—attention deficit hyperactivity disorder	0.00631	0.0131	CbGeAlD
Arsenic trioxide—JUN—cerebellum—attention deficit hyperactivity disorder	0.00619	0.0129	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—attention deficit hyperactivity disorder	0.00616	0.0128	CbGeAlD
Arsenic trioxide—MAPK3—brain—attention deficit hyperactivity disorder	0.00613	0.0128	CbGeAlD
Arsenic trioxide—AKT1—brain—attention deficit hyperactivity disorder	0.00578	0.012	CbGeAlD
Arsenic trioxide—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.00547	0.0114	CbGeAlD
Arsenic trioxide—JUN—brain—attention deficit hyperactivity disorder	0.00503	0.0105	CbGeAlD
Arsenic trioxide—IKBKB—brain—attention deficit hyperactivity disorder	0.00501	0.0104	CbGeAlD
Arsenic trioxide—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00351	0.00731	CbGeAlD
Arsenic trioxide—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00338	0.00704	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.0033	0.00688	CbGeAlD
Arsenic trioxide—CYP1B1—brain—attention deficit hyperactivity disorder	0.00268	0.00559	CbGeAlD
Arsenic trioxide—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00248	0.00517	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00239	0.00497	CbGeAlD
Arsenic trioxide—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00237	0.00494	CbGeAlD
Arsenic trioxide—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00201	0.00418	CbGeAlD
Arsenic trioxide—CYP1A1—brain—attention deficit hyperactivity disorder	0.0019	0.00395	CbGeAlD
Arsenic trioxide—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00182	0.00379	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00175	0.00365	CbGeAlD
Arsenic trioxide—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00157	0.00326	CbGeAlD
Arsenic trioxide—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00129	0.00268	CbGeAlD
Arsenic trioxide—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00124	0.00258	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00121	0.00253	CbGeAlD
Arsenic trioxide—ABCB1—brain—attention deficit hyperactivity disorder	0.000985	0.00205	CbGeAlD
Arsenic trioxide—MAPK3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000527	0.00101	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000526	0.00101	CbGpPWpGaD
Arsenic trioxide—JUN—TGF-beta Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000517	0.000995	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—STUB1—attention deficit hyperactivity disorder	0.000517	0.000995	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000516	0.000992	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—STUB1—attention deficit hyperactivity disorder	0.00051	0.000981	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000501	0.000964	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000498	0.000958	CbGpPWpGaD
Arsenic trioxide—AKT1—TGF-beta Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000497	0.000956	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000497	0.000956	CbGpPWpGaD
Arsenic trioxide—JUN—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000494	0.00095	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—STUB1—attention deficit hyperactivity disorder	0.000492	0.000946	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000491	0.000944	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000482	0.000927	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00048	0.000924	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000478	0.00092	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000477	0.000917	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000474	0.000913	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000474	0.000911	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000473	0.00091	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000468	0.0009	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000465	0.000894	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000465	0.000894	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000464	0.000892	CbGpPWpGaD
Arsenic trioxide—MAPK1—TGF-beta Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000459	0.000883	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000459	0.000882	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000455	0.000876	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000453	0.000871	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000451	0.000869	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000451	0.000867	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000446	0.000859	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000442	0.00085	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000441	0.000849	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000438	0.000842	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000435	0.000837	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000424	0.000816	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000422	0.000812	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000422	0.000812	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000415	0.000798	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000412	0.000793	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000406	0.000781	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000404	0.000777	CbGpPWpGaD
Arsenic trioxide—CCND1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00039	0.00075	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000389	0.000748	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000386	0.000743	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000385	0.000742	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000385	0.000741	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000384	0.000738	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000373	0.000718	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000373	0.000718	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00037	0.000712	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00037	0.000711	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000369	0.000709	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000367	0.000706	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000362	0.000697	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000362	0.000697	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000359	0.00069	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000358	0.000688	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000355	0.000683	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000354	0.000681	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00035	0.000674	CbGpPWpGaD
Arsenic trioxide—CCND1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000349	0.000671	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000345	0.000663	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000341	0.000657	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00034	0.000655	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000338	0.00065	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000338	0.000649	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000334	0.000642	CbGpPWpGaD
Arsenic trioxide—AKT1—TCF dependent signaling in response to WNT—EP300—attention deficit hyperactivity disorder	0.000333	0.00064	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00033	0.000635	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00033	0.000634	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000327	0.000629	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000322	0.00062	CbGpPWpGaD
Arsenic trioxide—AKT1—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000322	0.00062	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000321	0.000617	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000321	0.000617	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00032	0.000615	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000319	0.000613	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000314	0.000604	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000314	0.000604	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000313	0.000601	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000311	0.000598	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00031	0.000597	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000308	0.000593	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000305	0.000586	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0003	0.000576	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000299	0.000576	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000299	0.000575	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000297	0.000572	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000297	0.000572	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000296	0.000569	CbGpPWpGaD
Arsenic trioxide—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000294	0.000566	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000291	0.000559	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00029	0.000558	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00029	0.000558	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000289	0.000556	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000288	0.000554	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000285	0.000549	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000284	0.000547	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000283	0.000545	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000282	0.000542	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000281	0.000541	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000277	0.000534	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000277	0.000533	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000277	0.000532	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000276	0.000532	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000273	0.000526	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000272	0.000523	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000268	0.000515	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000265	0.000509	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000265	0.000509	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000263	0.000507	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000263	0.000506	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000262	0.000505	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00026	0.000501	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00026	0.0005	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000255	0.00049	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000253	0.000486	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000247	0.000474	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000472	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000242	0.000466	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000242	0.000466	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000236	0.000455	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000236	0.000455	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000235	0.000451	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000233	0.000449	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000233	0.000448	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000227	0.000436	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00022	0.000423	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00022	0.000423	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000218	0.000419	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000217	0.000417	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000212	0.000407	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000211	0.000406	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000202	0.000389	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000388	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000201	0.000387	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000201	0.000387	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000201	0.000386	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000199	0.000382	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000198	0.000381	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000196	0.000378	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000192	0.00037	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00019	0.000366	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000185	0.000355	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000184	0.000354	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000184	0.000354	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000178	0.000343	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000178	0.000343	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000177	0.00034	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000176	0.000338	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000176	0.000338	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000175	0.000337	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000174	0.000334	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000173	0.000333	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000173	0.000333	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000172	0.00033	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000171	0.00033	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00017	0.000326	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00017	0.000326	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.000324	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000168	0.000323	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000168	0.000323	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.000322	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000166	0.00032	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000166	0.00032	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000165	0.000318	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000165	0.000317	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000165	0.000317	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000163	0.000314	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000163	0.000314	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000161	0.00031	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000161	0.00031	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000309	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00016	0.000307	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000159	0.000306	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000159	0.000306	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000158	0.000304	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000157	0.000302	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000157	0.000301	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000156	0.000301	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.000299	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000155	0.000299	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000155	0.000298	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000154	0.000295	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000153	0.000294	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000151	0.000291	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000151	0.000291	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00015	0.000289	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000149	0.000286	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000148	0.000285	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000148	0.000284	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000147	0.000283	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000143	0.000275	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000141	0.000271	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000137	0.000263	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000136	0.000261	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000136	0.000261	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000135	0.000259	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000133	0.000257	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000133	0.000257	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000132	0.000255	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000128	0.000247	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000125	0.000241	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000124	0.000238	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000113	0.000217	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000109	0.000209	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000208	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000108	0.000208	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000108	0.000208	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000106	0.000205	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000105	0.000203	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000198	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.0001	0.000193	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.9e-05	0.00019	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.66e-05	0.000186	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.59e-05	0.000184	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EP300—attention deficit hyperactivity disorder	9.26e-05	0.000178	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EP300—attention deficit hyperactivity disorder	8.9e-05	0.000171	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.65e-05	0.000166	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EP300—attention deficit hyperactivity disorder	8.63e-05	0.000166	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.24e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EP300—attention deficit hyperactivity disorder	8.21e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.21e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EP300—attention deficit hyperactivity disorder	8.21e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.15e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EP300—attention deficit hyperactivity disorder	7.97e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.91e-05	0.000152	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EP300—attention deficit hyperactivity disorder	7.86e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EP300—attention deficit hyperactivity disorder	7.58e-05	0.000146	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—EP300—attention deficit hyperactivity disorder	6.88e-05	0.000132	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.67e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.67e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.56e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	6.56e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.51e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.1e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.99e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.75e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	5.72e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.58e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.33e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.31e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.08e-05	9.77e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.08e-05	9.76e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.04e-05	7.77e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.01e-05	7.72e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.52e-05	6.77e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.81e-05	5.41e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.73e-05	3.33e-05	CbGpPWpGaD
